Pekin Hardy Strauss Inc. reduced its stake in Medtronic PLC by 37.8% in Q3, selling 16,404 shares and retaining 26,990 shares valued at approximately $2.57 million. Despite this, Medtronic reported strong quarterly earnings, surpassing analyst expectations with EPS of $1.36 and revenue of $9.02 billion, and issued positive FY2026 guidance. The company also maintains an annualized dividend of $2.84, offering a 2.9% yield, and holds an average “Moderate Buy” rating from analysts with an average price target of $111.05.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Medtronic PLC $MDT Shares Sold by Pekin Hardy Strauss Inc.
Pekin Hardy Strauss Inc. reduced its stake in Medtronic PLC by 37.8% in Q3, selling 16,404 shares and retaining 26,990 shares valued at approximately $2.57 million. Despite this, Medtronic reported strong quarterly earnings, surpassing analyst expectations with EPS of $1.36 and revenue of $9.02 billion, and issued positive FY2026 guidance. The company also maintains an annualized dividend of $2.84, offering a 2.9% yield, and holds an average “Moderate Buy” rating from analysts with an average price target of $111.05.